Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

被引:0
|
作者
Belén Sádaba
Jose Ramón Azanza
Aintzane García-Bea
Luis Labeaga
Cristina Campo
Román Valiente
机构
[1] Clínica Universidad de Navarra,Clinical Pharmacology Service
[2] IdiSNA,Medical Department
[3] Navarra Institute for health Research,Clinical Research Department
[4] Faes Farma S. A.,undefined
[5] Faes Farma S. A.,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:265 / 272
页数:7
相关论文
共 50 条
  • [41] Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
    Sun, Feifei
    Liu, Yanping
    Li, Ting
    Lin, Pingping
    Jiang, Xin
    Li, Xin
    Wang, Chenjing
    Gao, Xiaomeng
    Ma, Yaping
    Fu, Yao
    Cao, Yu
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [42] Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
    Genis-Najera, Luis
    Sanudo-Maury, Maria Elena
    NEUROLOGY AND THERAPY, 2024, 13 (01) : 141 - 152
  • [43] Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
    Luis Genis-Najera
    Maria Elena Sañudo-Maury
    Neurology and Therapy, 2024, 13 : 141 - 152
  • [44] Bioequivalence of Two Tablet Formulations of Clopidogrel in Healthy Argentinian Volunteers: A Single-Dose, Randomized-Sequence, Open-Label Crossover Study
    Di Girolamo, Guillermo
    Czerniuk, Paola
    Bertuola, Roberto
    Keller, Guillermo A.
    CLINICAL THERAPEUTICS, 2010, 32 (01) : 161 - 170
  • [45] Evaluation of Crizotinib Absolute Bioavailability, the Bioequivalence of Three Oral Formulations, and the Effect of Food on Crizotinib Pharmacokinetics in Healthy Subjects
    Xu, Huiping
    O'Gorman, Melissa
    Boutros, Tanya
    Brega, Nicoletta
    Kantaridis, Constantino
    Tan, Weiwei
    Bello, Akintunde
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (01): : 104 - 113
  • [46] Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers
    Kano, Eunice Kazue
    Mori Koono, Eunice Emiko
    Schramm, Simone Grigoleto
    dos Reis Serra, Cristina Helena
    Abib Junior, Eduardo
    Pereira, Renata
    Takamatsu Freitas, Marcia Sayuri
    Iecco, Maria Cristina
    Porta, Valentina
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 51 (01) : 203 - 211
  • [47] A RANDOMIZED, OPEN-LABEL, CROSSOVER STUDY TO EVALUATE THE RELATIVE ORAL BIOAVAILABILITY OF 2 FORMULATIONS OF SEPIAPTERIN AND PALATABILITY AND THE FOOD EFFECT ON THE PHASE 3 FORMULATION IN HEALTHY SUBJECTS
    Gao, Lan
    Xia, Yi
    Ingalls, Kimberly
    Kaushik, Diksha
    Greenbaum, Rochelle
    Milner, Sarah
    Kong, Ron
    Smith, Neil
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (03) : 49 - 49
  • [48] Evaluation of the Bioequivalence of single 100-mg doses of two oral formulations of cyclosporin a microemulsion:: A randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers
    Pineyro-Lopez, Alfredo
    Pineyro-Garza, Everardo
    Torres-Alanis, Oscar
    Reyes-Araiza, Raul
    Gomez-Silva, Magdalena
    Waksman, Noemi
    Salazar-Leal, Martha E.
    Lujan-Rangel, Ruben
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 2049 - 2054
  • [49] A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults
    Park, Kyungsoo
    Kim, Yu Seun
    Kwon, Kwang-il
    Park, Min Soo
    Lee, Yoon Jung
    Kim, Kyung Hwan
    CLINICAL THERAPEUTICS, 2007, 29 (01) : 154 - 162
  • [50] An Open-Label, Randomized, Pivotal Bioequivalence Study of Oral Rolapitant
    Zhang, Zhi-Yi
    Wang, Jing
    Arora, Sujata
    Lu, Sharon
    Powers, Dan
    Kansra, Vikram
    Wang, Xiaodong
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (02): : 152 - 159